Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals
ContributorsLubomirov, Rubin; Arab, Mona; Rotger, Margalida; Fayet-Mello, Aurélie; Martinez, Raquel; Guidi, Monia; di Iulio, Julia; Cavassini, Matthias; Günthard, Huldrych F; Furrer, Hansjakob; Marzolini, Catia; Bernasconi, Enos; Calmy, Alexandra
Published inPharmacogenetics and genomics, vol. 23, no. 1, p. 9-18
Publication date2013
Abstract
Keywords
- Adolescent
- Adult
- Aged
- Aryl Hydrocarbon Hydroxylases/genetics
- Cytochrome P-450 CYP3A/genetics
- Female
- HIV Infections/drug therapy/epidemiology/genetics
- HIV Protease Inhibitors/pharmacokinetics/pharmacology
- HIV-1/drug effects/genetics
- Humans
- Male
- Middle Aged
- Models
- Statistical
- Pharmacogenetics
- Polymorphism
- Single Nucleotide/genetics
- Prognosis
- Prospective Studies
- Pyridazines/pharmacokinetics/pharmacology
- Switzerland/epidemiology
- Tissue Distribution
- Young Adult
Research groups
Citation (ISO format)
LUBOMIROV, Rubin et al. Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals. In: Pharmacogenetics and genomics, 2013, vol. 23, n° 1, p. 9–18. doi: 10.1097/FPC.0b013e32835ade82
Main files (1)
Article (Published version)
Identifiers
- PID : unige:32157
- DOI : 10.1097/FPC.0b013e32835ade82
- PMID : 23111422
Journal ISSN1744-6872
